Vault-13

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2023-08-14

Exempt reporting adviser since 2021 · other (specify)

As an employer

$466.6m reported value +1.0% vs Q1 2023
76positions
35.9%in top 10
18 new 16 added 23 reduced 17 sold out vs Q1 2023

Options: 8 call positions ($111.0m notional), 3 put positions ($62.9m notional) – listed below, not included above.

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SANOFI SPONSORED ADR SNY SNY 529,515 $28.5m6.12% 6.12% UnchangedShares held: Q3 2022 1.2m, Q4 2022 559.5k, Q1 2023 529.5k, Q2 2023 529.5k
2 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 285,060 $20.4m4.37% 4.37% UnchangedShares held: Q3 2022 897.1k, Q4 2022 400.1k, Q1 2023 285.1k, Q2 2023 285.1k
3 JOHNSON & JOHNSON COM JNJ JNJ 119,831 $19.8m4.25% 4.25% UnchangedShares held: Q3 2022 216.2k, Q4 2022 109.8k, Q1 2023 119.8k, Q2 2023 119.8k
4 NICE LTD SPONSORED ADR NICE NICE 87,482 $18.1m3.87% 3.87% ReducedShares held: Q3 2022 3.1k, Q4 2022 0, Q1 2023 115.5k, Q2 2023 87.5k -28.0k -28,000 -24.2%
5 AMAZON COM INC COM AMZN AMZN 124,300 $16.2m3.47% 3.47% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 85.7k, Q2 2023 124.3k +38.6k +38,620 45.1%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 723,061 $15.1m3.24% 3.24% AddedShares held: Q3 2022 822.7k, Q4 2022 710.6k, Q1 2023 683.1k, Q2 2023 723.1k +40.0k +40,000 5.9%
7 MERCK & CO INC COM MRK MRK 120,600 $13.9m2.98% 2.98% UnchangedShares held: Q3 2022 367.0k, Q4 2022 120.6k, Q1 2023 120.6k, Q2 2023 120.6k
8 ENPHASE ENERGY INC NOTE 3/0 ENPH 0 03.01.28 ENPH 0 03.01.28 14,310,000 $13.4m2.88% 2.88% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 10.7m, Q2 2023 14.3m +3.6m +3,585,000 33.4%
9 MICROSOFT CORP COM MSFT MSFT 34,312 $11.7m2.50% 2.50% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 54.6k, Q2 2023 34.3k -20.3k -20,311 -37.2%
10 PRAXIS PRECISION MEDICINES I COM COM 8,764,334 $10.1m2.16% 2.16% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 8.8m
11 NOVO-NORDISK A S ADR NVO NVO 56,540 $9.1m1.96% 1.96% ReducedShares held: Q3 2022 296.4k, Q4 2022 71.5k, Q1 2023 71.5k, Q2 2023 56.5k -15.0k -15,000 -21.0%
12 POINT BIOPHARMA GLOBAL INC COM COM 952,642 $8.6m1.85% 1.85% UnchangedShares held: Q3 2022 1.1m, Q4 2022 952.6k, Q1 2023 952.6k, Q2 2023 952.6k
13 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 183,696 $8.5m1.82% 1.82% UnchangedShares held: Q3 2022 173.7k, Q4 2022 183.7k, Q1 2023 183.7k, Q2 2023 183.7k
14 NOVA LTD COM NVMI NVMI 70,000 $8.2m1.76% 1.76% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 70.0k
15 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 312,625 $8.2m1.76% 1.76% ReducedShares held: Q3 2022 301.6k, Q4 2022 316.6k, Q1 2023 317.6k, Q2 2023 312.6k -5.0k -5,000 -1.6%
16 SHL TELEMEDICINE LTD SPONSORED ADS SHLT SHLT 714,573 $8.0m1.71% 1.71% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 714.6k
17 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,050,000 $7.9m1.69% 1.69% ReducedShares held: Q3 2022 776.3k, Q4 2022 0, Q1 2023 2.0m, Q2 2023 1.1m -989.5k -989,500 -48.5%
18 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 40,000 $7.6m1.63% 1.63% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 40.0k
19 DISC MEDICINE INC COM IRON IRON 170,578 $7.6m1.62% 1.62% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 220.0k, Q2 2023 170.6k -49.4k -49,435 -22.5%
20 ABBVIE INC COM ABBV ABBV 56,000 $7.5m1.62% 1.62% ReducedShares held: Q3 2022 162.3k, Q4 2022 60.0k, Q1 2023 63.0k, Q2 2023 56.0k -7.0k -7,000 -11.1%
21 ELI LILLY & CO COM LLY LLY 15,690 $7.4m1.58% 1.58% ReducedShares held: Q3 2022 143.6k, Q4 2022 25.7k, Q1 2023 31.7k, Q2 2023 15.7k -16.0k -16,000 -50.5%
22 MERUS N V COM MRUS MRUS 278,333 $7.3m1.57% 1.57% ReducedShares held: Q3 2022 313.3k, Q4 2022 317.0k, Q1 2023 337.0k, Q2 2023 278.3k -58.7k -58,660 -17.4%
23 IMMATICS N.V SHS IMTX IMTX 617,173 $7.1m1.53% 1.53% ReducedShares held: Q3 2022 795.4k, Q4 2022 780.9k, Q1 2023 780.9k, Q2 2023 617.2k -163.7k -163,679 -21.0%
24 MINERALYS THERAPEUTICS INC COM MLYS MLYS 405,400 $6.9m1.48% 1.48% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 339.0k, Q2 2023 405.4k +66.4k +66,400 19.6%
25 PALO ALTO NETWORKS INC COM PANW PANW 27,000 $6.9m1.48% 1.48% AddedShares held: Q3 2022 63.0k, Q4 2022 0, Q1 2023 20.0k, Q2 2023 27.0k +7.0k +7,000 35.0%
26 BIOGEN INC COM BIIB BIIB 23,846 $6.8m1.46% 1.46% ReducedShares held: Q3 2022 55.5k, Q4 2022 7.5k, Q1 2023 33.5k, Q2 2023 23.8k -9.7k -9,670 -28.9%
27 CAMTEK LTD ORD CAMT CAMT 189,494 $6.8m1.45% 1.45% ReducedShares held: Q3 2022 0, Q4 2022 110.0k, Q1 2023 239.5k, Q2 2023 189.5k -50.0k -50,000 -20.9%
28 KURA ONCOLOGY INC COM KURA KURA 603,287 $6.4m1.37% 1.37% UnchangedShares held: Q3 2022 790.0k, Q4 2022 558.3k, Q1 2023 603.3k, Q2 2023 603.3k
29 DAY ONE BIOPHARMACEUTICALS I COM COM 530,000 $6.3m1.36% 1.36% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 530.0k
30 INOZYME PHARMA INC COM COM 1,131,967 $6.3m1.35% 1.35% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.6m, Q1 2023 1.8m, Q2 2023 1.1m -649.9k -649,891 -36.5%
31 TOWER SEMICONDUCTOR LTD SHS NEW TSEM TSEM 167,446 $6.3m1.35% 1.35% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 167.4k
32 FUSION PHARMACEUTICALS INC COM COM 1,329,258 $6.2m1.33% 1.33% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.3m, Q2 2023 1.3m +45.7k +45,721 3.6%
33 NOVARTIS AG SPONSORED ADR NVS NVS 60,000 $6.1m1.30% 1.30% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 60.0k, Q2 2023 60.0k
34 SAGE THERAPEUTICS INC COM SAGE SAGE 128,000 $6.0m1.29% 1.29% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 155.0k, Q2 2023 128.0k -27.0k -27,000 -17.4%
35 JASPER THERAPEUTICS INC COM COM 4,274,008 $5.9m1.25% 1.25% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 4.0m, Q2 2023 4.3m +230.0k +230,000 5.7%
36 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 25,000 $5.8m1.24% 1.24% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 19.0k, Q2 2023 25.0k +6.0k +6,000 31.6%
37 SAREPTA THERAPEUTICS INC COM SRPT SRPT 50,000 $5.7m1.23% 1.23% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 44.0k, Q2 2023 50.0k +6.0k +6,000 13.6%
38 BRIDGEBIO PHARMA INC COM BBIO BBIO 321,635 $5.5m1.19% 1.19% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 562.0k, Q2 2023 321.6k -240.3k -240,348 -42.8%
39 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 160,000 $5.4m1.16% 1.16% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 160.0k
40 IVERIC BIO INC COM OPHT OPHT 134,414 $5.3m1.13% 1.13% ReducedShares held: Q3 2022 581.8k, Q4 2022 195.6k, Q1 2023 231.6k, Q2 2023 134.4k -97.2k -97,177 -42.0%
41 MORPHIC HLDG INC COM MORF MORF 90,000 $5.2m1.11% 1.11% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 90.0k
42 PFIZER INC COM PFE PFE 140,000 $5.1m1.10% 1.10% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 140.0k, Q2 2023 140.0k
43 COGENT BIOSCIENCES INC COM COGT COGT 420,000 $5.0m1.07% 1.07% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 300.0k, Q2 2023 420.0k +120.0k +120,000 40.0%
44 KEZAR LIFE SCIENCES INC COM COM 1,988,228 $4.9m1.04% 1.04% AddedShares held: Q3 2022 1.2m, Q4 2022 1.3m, Q1 2023 1.9m, Q2 2023 2.0m +100.0k +100,000 5.3%
45 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 236,000 $4.7m1.01% 1.01% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 236.0k, Q2 2023 236.0k
46 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 1,228,665 $4.7m1.00% 1.00% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.4m, Q2 2023 1.2m -1.1m -1,131,915 -48.0%
47 SPDR SER TR S&P BIOTECH XBI XBI 50,000 $4.2m0.89% 0.89% NewShares held: Q3 2022 0, Q4 2022 70.0k, Q1 2023 0, Q2 2023 50.0k
48 PTC THERAPEUTICS INC COM PTCT PTCT 100,100 $4.1m0.87% 0.87% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 159.1k, Q2 2023 100.1k -59.0k -59,000 -37.1%
49 ASTRIA THERAPEUTICS INC COM CATB CATB 471,018 $3.9m0.84% 0.84% AddedShares held: Q3 2022 0, Q4 2022 469.3k, Q1 2023 421.0k, Q2 2023 471.0k +50.0k +50,000 11.9%
50 QUALCOMM INC COM QCOM QCOM 32,000 $3.8m0.82% 0.82% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 32.0k
51 ENLIGHT RENEWABLE ENERGY LTD SHS ENLT ENLT 211,586 $3.8m0.80% 0.80% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 450.9k, Q2 2023 211.6k -239.3k -239,278 -53.1%
52 GSK PLC SPONSORED ADR GSK GSK 100,000 $3.6m0.76% 0.76% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 100.0k
53 TRAVERE THERAPEUTICS INC COM TVTX TVTX 213,462 $3.3m0.70% 0.70% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 187.5k, Q2 2023 213.5k +26.0k +25,962 13.8%
54 GILEAD SCIENCES INC COM GILD GILD 40,000 $3.1m0.66% 0.66% NewShares held: Q3 2022 105.1k, Q4 2022 0, Q1 2023 0, Q2 2023 40.0k
55 89BIO INC COM ETNB ETNB 135,000 $2.6m0.55% 0.55% NewShares held: Q3 2022 658.8k, Q4 2022 180.6k, Q1 2023 0, Q2 2023 135.0k
56 ARCELLX INC COMMON STOCK ACLX ACLX 77,488 $2.5m0.53% 0.53% ReducedShares held: Q3 2022 334.1k, Q4 2022 237.5k, Q1 2023 167.5k, Q2 2023 77.5k -90.0k -90,000 -53.7%
57 REZOLUTE INC COM NEW RZLT RZLT 1,155,897 $2.3m0.49% 0.49% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
58 SELECTA BIOSCIENCES INC COM COM 2,038,500 $2.3m0.49% 0.49% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.3m, Q2 2023 2.0m -286.5k -286,500 -12.3%
59 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 100,000 $2.2m0.46% 0.46% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 100.0k
60 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 200,000 $2.1m0.44% 0.44% UnchangedShares held: Q3 2022 200.0k, Q4 2022 200.0k, Q1 2023 200.0k, Q2 2023 200.0k
61 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 626,810 $1.9m0.41% 0.41% UnchangedShares held: Q3 2022 626.8k, Q4 2022 626.8k, Q1 2023 626.8k, Q2 2023 626.8k
62 ALTIMMUNE INC COM NEW ALT ALT 500,000 $1.8m0.38% 0.38% AddedShares held: Q3 2022 600.3k, Q4 2022 380.3k, Q1 2023 300.0k, Q2 2023 500.0k +200.0k +200,000 66.7%
63 UNIQURE NV SHS QURE QURE 148,734 $1.7m0.37% 0.37% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 62.0k, Q2 2023 148.7k +86.7k +86,734 139.9%
64 VERA THERAPEUTICS INC CL A VERA VERA 105,000 $1.7m0.36% 0.36% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 105.0k
65 RIGEL PHARMACEUTICALS INC COM NEW COM NEW 1,228,126 $1.6m0.34% 0.34% ReducedShares held: Q3 2022 2.2m, Q4 2022 2.3m, Q1 2023 1.9m, Q2 2023 1.2m -650.7k -650,719 -34.6%
66 COMPUGEN LTD ORD CGEN CGEN 1,229,808 $1.4m0.30% 0.30% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.2m
67 MERSANA THERAPEUTICS INC COM COM 418,562 $1.4m0.30% 0.30% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 10.6k, Q2 2023 418.6k +407.9k +407,941 3840.9%
68 ELEVATION ONCOLOGY INC COM COM 900,000 $1.4m0.29% 0.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 900.0k
69 DYNE THERAPEUTICS INC COM DYN DYN 119,918 $1.3m0.29% 0.29% ReducedShares held: Q3 2022 0, Q4 2022 7.1k, Q1 2023 219.3k, Q2 2023 119.9k -99.4k -99,398 -45.3%
70 INHIBRX INC COM INBX INBX 50,000 $1.3m0.28% 0.28% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 50.0k
71 MEDIWOUND LTD SHS NEW MDWD MDWD 111,127 $1.2m0.25% 0.25% UnchangedShares held: Q3 2022 0, Q4 2022 75.4k, Q1 2023 111.1k, Q2 2023 111.1k
72 PMV PHARMACEUTICALS INC COM PMVP PMVP 187,800 $1.2m0.25% 0.25% UnchangedShares held: Q3 2022 187.8k, Q4 2022 187.8k, Q1 2023 187.8k, Q2 2023 187.8k
73 IMMATICS N.V *W EXP 07/01/202 IMTXW IMTXW 100,000 $342.0k0.07% 0.07% UnchangedShares held: Q3 2022 100.0k, Q4 2022 100.0k, Q1 2023 100.0k, Q2 2023 100.0k
74 INFINITY PHARMACEUTICALS INC COM INFIQ INFIQ 1,476,000 $310.7k0.07% 0.07% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
75 CYCLACEL PHARMACEUTICALS INC COM COM 250,000 $147.3k0.03% 0.03% UnchangedShares held: Q3 2022 250.0k, Q4 2022 250.0k, Q1 2023 250.0k, Q2 2023 250.0k
76 ARBE ROBOTICS LTD ORDINARY SHARES ARBE ARBE 43,165 $124.7k0.03% 0.03% UnchangedShares held: Q3 2022 43.2k, Q4 2022 43.2k, Q1 2023 43.2k, Q2 2023 43.2k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
NUTRIEN LTD NTR NTR 145,466 $10.7m145.5k shares
INVESCO QQQ TR QQQ QQQ 26,353 $8.5m26.4k shares
BELLUS HEALTH INC NEW BLU BLU 799,860 $5.8m799.9k shares
PERION NETWORK LTD PERI PERI 130,000 $5.1m130.0k shares
KINIKSA PHARMACEUTICALS LTD 450,283 $4.8m450.3k shares
VAXCYTE INC PCVX PCVX 90,000 $3.4m90.0k shares
MIRUM PHARMACEUTICALS INC MIRM MIRM 109,336 $2.6m109.3k shares
AMGEN INC AMGN AMGN 10,000 $2.4m10.0k shares
CHINOOK THERAPEUTICS INC ADRO ADRO 92,200 $2.1m92.2k shares
CRINETICS PHARMACEUTICALS IN CRNX CRNX 82,747 $1.3m82.7k shares
KEROS THERAPEUTICS INC KROS KROS 30,119 $1.3m30.1k shares
ANNEXON INC ANNX ANNX 250,000 $962.5k250.0k shares
REATA PHARMACEUTICALS INC RETA RETA 7,689 $699.1k7.7k shares
FIVERR INTL LTD FVRR 0 11.01.25 FVRR 0 11.01.25 250,000 $208.2k250.0k shares
AEGLEA BIOTHERAPEUTICS INC AGLE AGLE 646,478 $187.5k646.5k shares
OTONOMO TECHNOLOGIES LTD 391,863 $186.4k391.9k shares
ONCORUS INC 540,258 $185.9k540.3k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
TEVA PHARMACEUTICAL INDS LTD Call Call 8,144,700 $61.3m8.1m shares Added
INVESCO QQQ TR QQQ · Put QQQPut 126,000 $46.5m126.0k shares New
ADVANCED MICRO DEVICES INC AMD · Call AMDCall 120,000 $13.7m120.0k shares New
TOWER SEMICONDUCTOR LTD TSEM · Put TSEMPut 332,100 $12.5m332.1k shares New
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 78,300 $9.0m78.3k shares New
GENERAC HLDGS INC GNRC · Call GNRCCall 52,500 $7.8m52.5k shares New
MICROSOFT CORP MSFT · Call MSFTCall 21,000 $7.2m21.0k shares New
ENPHASE ENERGY INC ENPH · Call ENPHCall 40,000 $6.7m40.0k shares New
ARGENX SE ARGX · Put ARGXPut 10,000 $3.9m10.0k shares New
NICE LTD NICE · Call NICECall 15,000 $3.1m15.0k shares New
BRIDGEBIO PHARMA INC BBIO · Call BBIOCall 130,000 $2.2m130.0k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 PMN 7.8% +2.3 pts 13G 2026-02-05
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 TENX 7.1%≈ $38.8m +1.8 pts 13G 2026-10-13